Efficacy of baclofen on abstinence and craving in alcohol-dependent patients: A meta-analysis of randomized controlled trials

Therapie

Volumn 69, Issue 5, 2014, Pages 427-435

  Lesouef, Nicolas ^a   Bellet, Florelle ^a   Mounier, Geneviève ^a   Beyens, Marie Noëlle ^a,b  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b University Jean Monnet of Saint Etienne EA3065   (France)

Author keywords

Alcohol drinking; Alcohol related disorders; Alcoholism; Baclofen; Meta analysis as topic; Randomized controlled trials as topic; Treatment outcome

Indexed keywords

BACLOFEN; PLACEBO;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; DRUG EFFICACY; HUMAN; MAINTENANCE THERAPY; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT DURATION; ADULT; DRUG EFFECTS; FEMALE; MALE; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ADULT; ALCOHOL ABSTINENCE; ALCOHOLISM; BACLOFEN; CRAVING; FEMALE; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84907942126     PISSN: 00405957     EISSN: 19585578     Source Type: Journal    
DOI: 10.2515/therapie/2014038     Document Type: Article

References (23)

1. Room R, Babor T, Rehm J. Alcohol and public health. Lancet 2005; 365: 519-30
2. Garbutt JC, West SL, Carey TS et al,. Pharmacological treatment of alcohol dependence: a review of the evidence. JAMA 1999; 281: 1318-25
3. Swift RM. Drug therapy for alcohol dependence. N Engl J Med 1999; 340: 1482-90
4. Kranzler HR. Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research. Alcohol Alcohol 2000; 35: 537-47
5. Davidoff RA. Antispasticity drugs: mechanisms of action. Ann Neurol 1985; 17: 107-16
6. Weiss F, Porrino LJ. Behavioral neurobiology of alcohol addiction: recent advances and challenges. J Neurosci 2002; 22: 3332-7
7. Bowery NG, Hudson AL, Price GW. GABAA and GABAB receptor site distribution in the rat central nervous system. Neuroscience 1987; 20: 365-83
8. Westerink BHC, Kwint H-F, de Vries JB. The pharmacology of mesolimbic dopamine neurons: a dual-probe micro dialysis study in the ventral tegmental area and nucleus accumbens of the rat brain. J Neurosci 1996; 16: 2605-11
9. Colombo G, Addolorato G, Agabio R et al,. Role of GABA(B) receptor in alcohol dependence: reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics. Neurotox Res 2004; 6: 403-14
10. Flannery BA, Garbutt JC, Cody MW et al,. Baclofen for alcohol dependence: a preliminary open-label study. Alcohol Clin Exp Res 2004; 28: 1517-23
11. Ameisen O. Complete and prolonged suppression of symptoms and consequences of alcohol-dependance using high dose of baclofen: a self case report of a physician. Alcohol Alcohol 2005; 40: 147-50
12. Higgins JP, Altman DJ, Gotzsche PC et al,. The Cochrane collaboration's tool for assessing risk of bias in randomised trial. BMJ 2011; 343: d5928
13. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-58
14. Rücker G, Schwarzer G, Carpenter JR et al,. Undue reliance on I(2) in assessing heterogeneity may mislead. BMC Med Res Methodol 2008; 8: 79
15. Deeks J, Altman D, Bradburn M. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Smith G, Altman D, editors, Systematic reviews in health care: Meta-analysis in context, 2th edn. London: BMJ Publishing Group. 2001
16. Higgins JP, Thompson SG, Deeks JJ et al,. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60
17. Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med 2004; 23: 1351-75
18. Addolorato G, Caputo F, Capristo E et al,. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol Alcohol 2002; 37: 504-8
19. Addolorato G, Leggio L, Ferrulli A et al,. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet 2007; 370: 1915-22
20. th, 2014 (6 pages)
21. Garbutt JC, Kalka-Juhl L, Kampov-Polevoy A et al,. Feasibility and tolerability of combining baclofen and naltrexone for alcohol dependence: a pilot study. Alcohol Clin Exp Res 2010; 34: 6 (178A)
22. Garbutt JC, Kampov-Polevoy AB, Gallop R et al,. Efficacy and Safety of Baclofen for Alcohol Dependence: a randomized, double-blind, placebo-controlled trial. Alcohol Clin Exp Res 2010; 34: 1849-57
23. Muzyk AJ, Rivelli SK, Gagliardi JP. Defining the role of baclofen for the treatment of alcohol dependance: a systematic review of the evidence. CNS Drugs 2012; 26: 69-78